Association of peroxisome proliferator-activated receptor α/δ/γ with obesity, and gene-gene interaction, in the chinese han population

Journal of Epidemiology

Volumn 23, Issue 3, 2013, Pages 187-194

  Luo, Wenshu ^a,b   Guo, Zhirong ^b   Wu, Ming ^c   Hao, Chao ^a   Hu, Xiaoshu ^d   Zhou, Zhengyuan ^e   Zhou, Zhiwu ^a   Yao, Xingjuan ^a   Zhang, Lijun ^b   Liu, Jingchao ^b  

^a Changzhou Center for Disease Control and Prevention   (China)

^b SOOCHOW UNIVERSITY   (China)

^c Center for Diseases Control of Jiangsu Province   (China)

^d Health Bureau of JiangSu Province   (China)

^e Center for Disease Control of Changshu   (China)

Author keywords

BMI; Interaction; Peroxisome proliferator activated receptors; Polymorphism

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ALLELE; ARTICLE; BODY MASS; CHINA; EPISTASIS; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; OBESITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; BASE SEQUENCE; BODY MASS INDEX; CHINA; EPISTASIS, GENETIC; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR ALPHA; PPAR DELTA; PPAR GAMMA;

MLCS; MLOWN;

EID: 84879942338     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20120110     Document Type: Article

References (37)

1. James PT, Rigby N, Leach R; International Obesity Task Force. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil. 2004;11:3-8.
2. Stunkard AJ, Foch TT, Hrubec Z. A twin study of human obesity. JAMA. 1986;256:51-4.
3. Faith MS, Pietrobelli A, Nuñez C, Heo M, Heymsfield SB, Allison DB. Evidence for independent genetic influences on fat mass and body mass index in a pediatric twin sample. Pediatrics. 1999;104 1 Pt 1:61-7.
4. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990;347:645-50.
5. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W. Control of the peroxisomal ß-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 1992;68:879-87.
6. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA. 1994;91:7355-9.
7. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science. 2001;294:1866-70.
8. Bossé Y, Després JP, Bouchard C, Pérusse L, Vohl MC. The peroxisome proliferator-activated receptor L162V mutation is associated with reduced adiposity. Obes Res. 2003;11:809-16.
9. Evans D, Aberle J, Wendt D, Wolf A, Beisiegel U, Mann WA. A polymorphism, L162V, in the peroxisome proliferator-activated receptor a (PPARa) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus. J Mol Med (Berl). 2001;79(4):198-204.
10. Rhee EJ, Oh KW, Lee WY, Kim SY, Oh ES, Baek KH, et al. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-? gene on metabolic syndrome. Arch Med Res. 2006;37:86-94.
11. Cecil JE, Watt P, Palmer CN, Hetherington M. Energy balance and food intake: The role of PPAR? gene polymorphisms. Physiol Behav. 2006;88:227-33.
12. Fornage M, Jacobs DR, Steffes MW, Gross MD, Bray MS, Schreiner PJ. Inverse effects of the PPAR?2 Pro12Ala polymorphism on measures of adiposity over 15 years in African Americans and whites: The CARDIA study. Metabolism. 2005;54:910-7.
13. Shin HD, Park BL, Kim LH, Jung HS, Cho YM, Moon MK, et al. Genetic polymorphisms in peroxisome proliferatoractivated receptor delta associated with obesity. Diabetes. 2004;53(3):847-51.
14. Aberle J, Hopfer I, Beil FU, Seedorf U. Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferatoractivated receptor alpha L162V. Int J Obes (Lond). 2006; 30(12):1709-13.
15. Zhou H, Guo ZR, Yu LG, Hu XS, Xu BH, Liu HB, et al. Evidence on the applicability of the ATPIII, IDF and CDS metabolic syndrome diagnostic criteria to identify CVD and T2DM in the Chinese population from a 6.3-year cohort study in mid-eastern China. Diabetes Res Clin Pract. 2010;90:319-25.
16. Report of a WHO Consultation. Obesity: Preventing and managing the global epidemic. WHO Technical Report Series, Geneva, 2000.894.
17. Lohman T, Roche AF, Martorell R. Standardization of anthropometric measurements. Champaign, IL: Human Kinetics; 1988.
18. Hardy GH. MENDELIAN PROPORTIONS IN A MIXED POPULATION. Science. 1908;28(706):49-50.
19. Weinberg W. On the demonstration of heredity in man. In: Boyer SH, editor. (1963) Papers on human genetics. Englewood Cliffs, NJ: Prentice-Hall; 1908.
20. Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, Elston RC, et al. A generalized combinatorial approach for detecting gene-by gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet. 2007;80(6):1125-37.
21. Yu XJ, Su BL, Wang XM, Jin CJ, Qu JM, Feng HJ. The relationship of some indices of glycometabolism with peroxisome proliferator-activated receptor delta polymorphism. Chin J Diabetes. 2007;15(10):596-7.
22. Skogsberg J, Kannisto K, Cassel TN, Hamsten A, Eriksson P, Ehrenborg E. Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men. Arterioscler Thromb Vasc Biol. 2003;23(4):637-43.
23. Skogsberg J, McMahon AD, Karpe F, Hamsten A, Packard CJ, Ehrenborg E; West of Scotland Coronary Prevention Study. Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men. J Intern Med. 2003;254(6):597-604.
24. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, et al. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obestiy. Cell. 2003;113:159-70.
25. Oliver WR Jr, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, et al. A selective peroxisome proliferator-activated receptors d agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA. 2001;98:5306-11.
26. Auwerx J. PPARgamma, the ultimate thrifty gene. Diabetologia. 1999;42:1033-49.
27. Rosen ED, Spiegelman BM. PPAR gamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem. 2001;276(41):37731-4.
28. Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, et al. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 2002;16:22-6.
29. Vidal-Puig AJ, Considine RV, Jimenez-Liñan M, Werman A, Pories WJ, Caro JF, et al. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest. 1997;99(10):2416-22.
30. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J, et al. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes. 1998;47(1): 98-103.
31. Meirhaeghe A, Fajas L, Gouilleux F, Cottel D, Helbecque N, Auwerx J, et al. A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population. Arterioscler Thromb Vasc Biol. 2003;23:289-94.
32. Rieusset J, Seydoux J, Anghel SI, Escher P, Michalik L, Soon Tan N, et al. Altered growth in male PPARgamma heterozygous mice: involvement of PPARgamma in a negative feed-back regulation of growth hormone action. Mol Endocrinol. 2004; 18(10):2363-77.
33. Cecil JE, Fischer B, Doney AS, Hetherington M, Watt P, Wrieden W, et al. The Pro12Ala and C-681G variants of the PPARG locus are associated with opposing growth phenotypes in children. Diabetologia. 2005;48(8):1496-502.
34. Fisher R. The correlation between relatives on the supposition of Mendelian inheritance. Trans R Soc Edinb. 1919;52:399-433.
35. Consilvio C, Vincent AM, Feldman EL. Neuroinflammation, COX-2, and ALS-a dual role? Exp Neurol. 2004;187:1-10.
36. Shi Y, Hon M, Evans RM. The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling. Proc Natl Acad Sci USA. 2002;99: 2613-8.
37. Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y, et al. Activation of peroxisome proliferator activated receptor d induced fatty acid ß-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA. 2003;100: 15924-9.